Stoke Therapeutics Inc. (STOK) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Stoke Therapeutics Inc.

NASDAQ: STOK · Real-Time Price · USD
25.56
0.74 (2.98%)
At close: Oct 03, 2025, 3:59 PM
25.95
1.53%
After-hours: Oct 03, 2025, 07:40 PM EDT

Stoke Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
127.98M 191.44M 113.56M 144.9M
Short-Term Investments
88.92M 9.95M 116.04M 74.92M
Long-Term Investments
29.82M 569K 569K 569K
Other Long-Term Assets
721K n/a n/a n/a
Receivables
700K 64K 588K 132K
Inventory
n/a n/a 10.93M n/a
Other Current Assets
4.04M 2.56M -7.98M 2.33M
Total Current Assets
232.76M 215.34M 244.07M 229.22M
Property-Plant & Equipment
8.25M 12.43M 11.43M 9.08M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
38.8M 13M 12M 9.65M
Total Assets
271.56M 228.34M 256.07M 238.87M
Account Payables
2.5M 1.7M 766K 2.38M
Deferred Revenue
18.99M 15.31M 14.88M n/a
Short-Term Debt
2.32M 2.06M 2.36M 1.51M
Other Current Liabilities
6.12M 4.41M 5.28M -967K
Total Current Liabilities
40.06M 30.82M 31.39M 17.14M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
26K 4.88M 2.97M 417K
Total Long-Term Liabilities
2.48M 37.96M 39.82M 3.95M
Total Liabilities
42.53M 68.78M 71.22M 21.09M
Total Debt
2.32M 2.06M 2.36M 1.51M
Book Value
229.02M 159.56M 184.85M 217.78M
Book Value Per Share
4.24 3.63 4.75 5.93
Common Stock
5K 5K 4K 4K
Retained Earnings
-490.83M -401.85M -297.15M -196.08M
Comprehensive Income
-151K -24K -1.18M -168K
Shareholders Equity
229.02M 159.56M 184.85M 217.78M
Total Investments
118.74M 9.95M 116.04M 74.92M